About half of infected people show no symptoms, but in others gonorrhea can lead to painful joints and burning urination. It has become resistant to azithromycin and is increasingly resistant to another antibiotic called ceftriaxone, which is now the standard of care. Based on previous research, the drug is unlikely to be as effective in the throat and rectum, said Dr. Marrazzo. In studies, zoliflodacin appears to be effective against a wide range of resistant strains of gonorrhea. The partnership’s agreement minimizes that chance: The nonprofit plans to manage how the drug is distributed, and to see that it is used only to treat gonorrhea.

---

Persons: gonorrhea, ”, Manica Balasegaram, “ I’ll, that’s, Ramanan Laxminarayan, Jeanne Marrazzo, Marrazzo, zoliflodacin, Margaret Koziel Organizations: Global, Research, Development, Pharmaceutical, European Union, Therapeutics, Princeton University, National Institute of Allergy Locations: American